Melatonin's Effects on Treatment Of Diabetes Mellitus

• Status: Unknown status
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to assess the efficacy and safety of melatonin in control of blood sugar in patients with type 2 diabetes mellitus (DM).

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shiraz University of Medical Sciences
• Treatments: Melatonin

Criteria

Inclusion Criteria:

• Type 2 diabetes mellitus diagnosed by an endocrinologist for more than six months

• FBS=120-160mg/dl

• HbA1C<8%

Exclusion Criteria:

• Melatonin sensitivity

• Impaired fasting glucose (IFG)

• Impaired glucose tolerance (IGT)

• Under Insulin therapy

• Pregnancy

• Lactation

• Diabetic autonomic neuropathy and orthostatic hypotension

• Renal failure (Creatinin>1.5mg/dl)

• Diabetic retinopathy

• Diabetic nephropathy

• Malignancy

• Alcohol use

• Liver disease